Patrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End
Mr. McEnany will Continue to Serve as Catalyst’s Non-Executive Chairman of the Board Following his…
News
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic…
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic…
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
InspireMD to Report Second Quarter 2023 Financial Results and Provide Corporate Business Update on Tuesday, August 8th
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel and…
InspireMD to Report Second Quarter 2023 Financial Results and Provide Corporate Business Update on Tuesday, August 8th
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel and…
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine…
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine…
Spectral Medical Announces Tigris Clinical Trial Update
Enrollment momentum continues as Tigris Trial reaches 69 patients TORONTO, July 25, 2023 (GLOBE NEWSWIRE)…
Spectral Medical Announces Tigris Clinical Trial Update
Enrollment momentum continues as Tigris Trial reaches 69 patients TORONTO, July 25, 2023 (GLOBE NEWSWIRE)…
Orlando International Airport deploys Tellabs Optical LAN for high-speed, future-proof, energy-saving gains
Orlando International Airport is one of the first airports to install 10 gigabit Passive Optical…
Orlando International Airport deploys Tellabs Optical LAN for high-speed, future-proof, energy-saving gains
Orlando International Airport is one of the first airports to install 10 gigabit Passive Optical…
Personal Data Removal Startup Optery Achieves SOC 2 Type II Security Certification
Audit demonstrates that Optery manages customer data with the highest standard of security and compliance Optery…
Personal Data Removal Startup Optery Achieves SOC 2 Type II Security Certification
Audit demonstrates that Optery manages customer data with the highest standard of security and compliance Optery…
Spectrum Control Beams in New Digital Growth Strategy with HawkSearch
WOBURN, Mass., July 25, 2023 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a key…
Spectrum Control Beams in New Digital Growth Strategy with HawkSearch
WOBURN, Mass., July 25, 2023 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a key…
BYND Cannasoft Provides EZ-G Device Milestones for the Second Half of 2023
ASHKELON, Israel and VANCOUVER, British Columbia, July 25, 2023 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises…
BYND Cannasoft Provides EZ-G Device Milestones for the Second Half of 2023
ASHKELON, Israel and VANCOUVER, British Columbia, July 25, 2023 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises…
Cerence Introduces Low-Footprint Product Suite Designed Specifically for IoT Applications
CVNet is first customer to leverage new innovation from Cerence for smart home control BURLINGTON,…